RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Sino Biopharmaceutical
S

Sino Biopharmaceutical portfolio

Sino Biopharmaceutical has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 1.
Capital in their rounds: $60M.
Latest deal: Phrontline Biopharma · Nov 24, 2025.
About this page

Its most recent investment on record is Phrontline Biopharma's $60M Seed round in November 2025, alongside Hankang Capital, Xiamen C&D Emerging Industry Equity Investment, Songqing Capital and 6 others. That company is in Health and bio.

What Sino Biopharmaceutical invests in

How Sino Biopharmaceutical invests

StageDealsCapital in rounds
Seed 1 100%$60M

Sino Biopharmaceutical portfolio companies

CompanyRound with Sino BiopharmaceuticalTotal raisedLatest raise
PPhrontline Biopharma
Health and bio
Seed · $60M$100MNov 12, 2026
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name Sino Biopharmaceutical. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Sino Biopharmaceutical, which is a subset of its real portfolio. API: /api/v1/investors/sino-biopharmaceutical (get a free API key). More: the most active VC firms and new venture capital funds.